|Page (1) of 1 - 12/06/17||email article||print page|
(December 06, 2017)
HORSHAM, Pa., Dec. 06, 2017 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ:SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Christina Allgeier resigned as Chief Financial Officer to pursue other opportunities and to commence the next chapter in her career. Ms. Allgeier intends to remain in her current role through December 31st.
Jeff O’Donnell, Chairman of the Board stated, “We wish Christina well and thank her for her years of service; we have commenced a search for her replacement.”
Ms. Allgeier has agreed to assist the Company during the transition period as it searches for a new Chief Financial Officer by entering into a transition services agreement, under which she will provide STRATA with consulting services through March 31, 2018.
About STRATA Skin Sciences, Inc. (www.strataskinsciences.com)
STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions. Its products include the XTRAC® laser and VTRAC® excimer lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions; the STRATAPEN™ MicroSystem, marketed specifically for the intended use of micropigmentation; and Nordlys, a multi-technology aesthetic laser device.
TrademarksEllipse and Nordlys are trademarks of Ellipse S/A, Horsholm, Denmark.
|Frank McCaney, Chief Executive Officer||Bob Yedid, Managing Director|
|STRATA Skin Sciences, Inc.||LifeSci Advisors, LLC|
|[email protected]||[email protected]|
Related Sites: DMN Newswire , USDailyNews , HTN - Health Technology Net
Related Newsletter: Tutorial Finder , Review Seeker , DMN Newswire Newsletter